Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 208

1.

Nocturnal Excretion in Healthy Older Women and Rationale for a Safer Approach to Sleep Disruption.

Tyagi S, Perera S, Clarkson BD, Tadic SD, Resnick NM.

J Am Geriatr Soc. 2019 Dec;67(12):2610-2614. doi: 10.1111/jgs.16144. Epub 2019 Aug 22.

PMID:
31437310
2.

Functional deficiency in endogenous interleukin-1 receptor antagonist in patients with febrile infection-related epilepsy syndrome.

Clarkson BDS, LaFrance-Corey RG, Kahoud RJ, Farias-Moeller R, Payne ET, Howe CL.

Ann Neurol. 2019 Apr;85(4):526-537. doi: 10.1002/ana.25439. Epub 2019 Mar 8.

3.

Functional connectivity of the brain in older women with urgency urinary incontinence.

Clarkson BD, Karim HT, Griffiths DJ, Resnick NM.

Neurourol Urodyn. 2018 Nov;37(8):2763-2775. doi: 10.1002/nau.23766. Epub 2018 Jul 27.

4.

Do brain structural abnormalities differentiate separate forms of urgency urinary incontinence?

Clarkson BD, Griffiths D, Resnick NM.

Neurourol Urodyn. 2018 Nov;37(8):2597-2605. doi: 10.1002/nau.23591. Epub 2018 Apr 19.

5.

Retrograde interferon-gamma signaling induces major histocompatibility class I expression in human-induced pluripotent stem cell-derived neurons.

Clarkson BDS, Patel MS, LaFrance-Corey RG, Howe CL.

Ann Clin Transl Neurol. 2017 Dec 21;5(2):172-185. doi: 10.1002/acn3.516. eCollection 2018 Feb.

6.

Inflammatory cytokine-induced changes in neural network activity measured by waveform analysis of high-content calcium imaging in murine cortical neurons.

Clarkson BDS, Kahoud RJ, McCarthy CB, Howe CL.

Sci Rep. 2017 Aug 22;7(1):9037. doi: 10.1038/s41598-017-09182-5.

7.

CCR7 deficient inflammatory Dendritic Cells are retained in the Central Nervous System.

Clarkson BD, Walker A, Harris MG, Rayasam A, Hsu M, Sandor M, Fabry Z.

Sci Rep. 2017 Feb 20;7:42856. doi: 10.1038/srep42856.

8.

Exotic weeds and fluctuating microclimate can constrain native plant regeneration in urban forest restoration.

Wallace KJ, Laughlin DC, Clarkson BD.

Ecol Appl. 2017 Jun;27(4):1268-1279. doi: 10.1002/eap.1520. Epub 2017 Apr 10.

PMID:
28182314
9.

Effect of purified fractions from cell culture supernate of high-density pre-B acute lymphoblastic leukemia cells (ALL3) on the growth of ALL3 cells at low density.

Patel SJ, Darie CC, Clarkson BD.

Electrophoresis. 2017 Feb;38(3-4):417-428. doi: 10.1002/elps.201600399. Epub 2016 Nov 28.

10.

Test-retest repeatability of patterns of brain activation provoked by bladder filling.

Clarkson BD, Tyagi S, Griffiths DJ, Resnick NM.

Neurourol Urodyn. 2017 Aug;36(6):1472-1478. doi: 10.1002/nau.23153. Epub 2016 Oct 24.

11.

Exosome mediated growth effect on the non-growing pre-B acute lymphoblastic leukemia cells at low starting cell density.

Patel SJ, Darie CC, Clarkson BD.

Am J Transl Res. 2016 Sep 15;8(9):3614-3629. eCollection 2016.

12.

The possible roles of B-cell novel protein-1 (BCNP1) in cellular signalling pathways and in cancer.

Patel SJ, Trivedi GL, Darie CC, Clarkson BD.

J Cell Mol Med. 2017 Mar;21(3):456-466. doi: 10.1111/jcmm.12989. Epub 2016 Sep 29.

13.

Nocturnal Polyuria in Older Women with Urge Urinary Incontinence: Role of Sleep Quality, Time in Bed and Medications Used.

Tyagi S, Perera S, Clarkson BD, Tadic SD, Resnick NM.

J Urol. 2017 Mar;197(3 Pt 1):753-758. doi: 10.1016/j.juro.2016.09.080. Epub 2016 Sep 25.

14.

Neuropilin-1 modulates interferon-γ-stimulated signaling in brain microvascular endothelial cells.

Wang Y, Cao Y, Mangalam AK, Guo Y, LaFrance-Corey RG, Gamez JD, Atanga PA, Clarkson BD, Zhang Y, Wang E, Angom RS, Dutta K, Ji B, Pirko I, Lucchinetti CF, Howe CL, Mukhopadhyay D.

J Cell Sci. 2016 Oct 15;129(20):3911-3921. Epub 2016 Sep 2.

15.
16.

Commentary on Sandberg et al., "The In Vivo Chromosome Constitution of Marrow".

Clarkson BD.

Cancer Res. 2016 Mar 1;76(5):991-3. doi: 10.1158/0008-5472.CAN-16-0153. No abstract available.

17.
18.

Mapping the accumulation of co-infiltrating CNS dendritic cells and encephalitogenic T cells during EAE.

Clarkson BD, Walker A, Harris M, Rayasam A, Sandor M, Fabry Z.

J Neuroimmunol. 2014 Dec 15;277(1-2):39-49. doi: 10.1016/j.jneuroim.2014.09.016. Epub 2014 Sep 28.

19.

Cancer secretomes and their place in supplementing other hallmarks of cancer.

Patel S, Ngounou Wetie AG, Darie CC, Clarkson BD.

Adv Exp Med Biol. 2014;806:409-42. doi: 10.1007/978-3-319-06068-2_20. Review.

PMID:
24952195
20.

Deficient import of acetyl-CoA into the ER lumen causes neurodegeneration and propensity to infections, inflammation, and cancer.

Peng Y, Li M, Clarkson BD, Pehar M, Lao PJ, Hillmer AT, Barnhart TE, Christian BT, Mitchell HA, Bendlin BB, Sandor M, Puglielli L.

J Neurosci. 2014 May 14;34(20):6772-89. doi: 10.1523/JNEUROSCI.0077-14.2014.

21.

Immune privilege of the CNS is not the consequence of limited antigen sampling.

Harris MG, Hulseberg P, Ling C, Karman J, Clarkson BD, Harding JS, Zhang M, Sandor A, Christensen K, Nagy A, Sandor M, Fabry Z.

Sci Rep. 2014 Mar 21;4:4422. doi: 10.1038/srep04422.

22.

T cell-derived interleukin (IL)-21 promotes brain injury following stroke in mice.

Clarkson BD, Ling C, Shi Y, Harris MG, Rayasam A, Sun D, Salamat MS, Kuchroo V, Lambris JD, Sandor M, Fabry Z.

J Exp Med. 2014 Apr 7;211(4):595-604. doi: 10.1084/jem.20131377. Epub 2014 Mar 10.

23.

Automated mass spectrometry-based functional assay for the routine analysis of the secretome.

Ngounou Wetie AG, Sokolowska I, Woods AG, Wormwood KL, Dao S, Patel S, Clarkson BD, Darie CC.

J Lab Autom. 2013 Feb;18(1):19-29. doi: 10.1177/2211068212454738. Epub 2012 Aug 1. Review.

PMID:
22853965
24.

Innate-adaptive crosstalk: how dendritic cells shape immune responses in the CNS.

Clarkson BD, Héninger E, Harris MG, Lee J, Sandor M, Fabry Z.

Adv Exp Med Biol. 2012;946:309-33. doi: 10.1007/978-1-4614-0106-3_18. Review.

25.

Gene Expression Differences between Enriched Normal and Chronic Myelogenous Leukemia Quiescent Stem/Progenitor Cells and Correlations with Biological Abnormalities.

Affer M, Dao S, Liu C, Olshen AB, Mo Q, Viale A, Lambek CL, Marr TG, Clarkson BD.

J Oncol. 2011;2011:798592. doi: 10.1155/2011/798592. Epub 2011 Feb 23.

26.

The role of dendritic cells in CNS autoimmunity.

Zozulya AL, Clarkson BD, Ortler S, Fabry Z, Wiendl H.

J Mol Med (Berl). 2010 Jun;88(6):535-44. doi: 10.1007/s00109-010-0607-4. Epub 2010 Mar 9. Review.

27.

Mechanisms of sunitinib resistance in gastrointestinal stromal tumors harboring KITAY502-3ins mutation: an in vitro mutagenesis screen for drug resistance.

Guo T, Hajdu M, Agaram NP, Shinoda H, Veach D, Clarkson BD, Maki RG, Singer S, Dematteo RP, Besmer P, Antonescu CR.

Clin Cancer Res. 2009 Nov 15;15(22):6862-70. doi: 10.1158/1078-0432.CCR-09-1315. Epub 2009 Oct 27.

28.

Sorafenib inhibits the imatinib-resistant KITT670I gatekeeper mutation in gastrointestinal stromal tumor.

Guo T, Agaram NP, Wong GC, Hom G, D'Adamo D, Maki RG, Schwartz GK, Veach D, Clarkson BD, Singer S, DeMatteo RP, Besmer P, Antonescu CR.

Clin Cancer Res. 2007 Aug 15;13(16):4874-81.

29.

L576P KIT mutation in anal melanomas correlates with KIT protein expression and is sensitive to specific kinase inhibition.

Antonescu CR, Busam KJ, Francone TD, Wong GC, Guo T, Agaram NP, Besmer P, Jungbluth A, Gimbel M, Chen CT, Veach D, Clarkson BD, Paty PB, Weiser MR.

Int J Cancer. 2007 Jul 15;121(2):257-64.

30.

New understanding of the pathogenesis of CML: a prototype of early neoplasia.

Clarkson BD, Strife A, Wisniewski D, Lambek C, Carpino N.

Leukemia. 1997 Sep;11(9):1404-28. Review.

31.

Long-term survivors in chronic granulocytic leukaemia: a study by the International CGL Prognosis Study Group. Italian Cooperative CML Study Group.

Cervantes F, Robertson JE, Rozman C, Baccarani M, Tura S, Gómez GA, Braun TJ, Clarkson BD, Pereira A.

Br J Haematol. 1994 Jun;87(2):293-300.

PMID:
7947270
32.
34.

TGF-beta 3 protects normal human hematopoietic progenitor cells treated with 4-hydroperoxycyclophosphamide in vitro.

Lemoli RM, Strife A, Clarkson BD, Haley JD, Gulati SC.

Exp Hematol. 1992 Dec;20(11):1252-6.

PMID:
1493854
35.

Consistent genetic abnormalities in human cancers as targets for selective therapies.

Clarkson BD.

Mt Sinai J Med. 1992 Oct;59(5):400-4. Review. No abstract available.

PMID:
1435835
36.

Phorbol ester-induced hairy cell features on chronic lymphocytic leukemia cells in vitro.

al-Katib A, Wang CY, McKenzie S, Clarkson BD, Koziner B.

Am J Hematol. 1992 Aug;40(4):264-9.

PMID:
1354412
37.

A phase II pilot trial of high-dose hydroxyurea in chronic myelogenous leukemia.

Kolitz JE, Kempin SJ, Schluger A, Wong GY, Berman E, Jhanwar S, Arlin ZA, Gee T, Clarkson BD.

Semin Oncol. 1992 Jun;19(3 Suppl 9):27-33.

PMID:
1641654
38.

Proliferation of human hematopoietic progenitors in long-term bone marrow cultures in gas-permeable plastic bags is enhanced by colony-stimulating factors.

Lemoli RM, Tafuri A, Strife A, Andreeff M, Clarkson BD, Gulati SC.

Exp Hematol. 1992 Jun;20(5):569-75.

PMID:
1587303
39.

Impact of adjuvant radiation on the patterns and rate of relapse in advanced-stage Hodgkin's disease treated with alternating chemotherapy combinations.

Yahalom J, Ryu J, Straus DJ, Gaynor JJ, Myers J, Caravelli J, Clarkson BD, Fuks Z.

J Clin Oncol. 1991 Dec;9(12):2193-201.

PMID:
1960560
40.

Duration of the preclinical phase of chronic myelogenous leukemia: a case report.

Berman E, Strife A, Wisniewski D, Desai S, Gulati S, Jhanwar S, Clarkson BD.

Blood. 1991 Dec 1;78(11):2969-72.

PMID:
1954384
41.

The effects of transforming growth factor beta 3 on the growth of highly enriched hematopoietic progenitor cells derived from normal human bone marrow and peripheral blood.

Strife A, Lambek C, Perez A, Darzynkiewicz Z, Skierski J, Gulati S, Haley JD, ten Dijke P, Iwata KK, Clarkson BD.

Cancer Res. 1991 Sep 15;51(18):4828-36.

43.

Autologous bone marrow transplantation in acute myelogenous leukemia: in vitro treatment with myeloid-specific monoclonal antibodies and drugs in combination.

Lemoli RM, Gasparetto C, Scheinberg DA, Moore MA, Clarkson BD, Gulati SC.

Blood. 1991 Apr 15;77(8):1829-36.

PMID:
2015406
44.

Mathematical model of granulocytopoiesis and chronic myelogenous leukemia.

Fokas AS, Keller JB, Clarkson BD.

Cancer Res. 1991 Apr 15;51(8):2084-91.

45.

Small non-cleaved-cell lymphoma (undifferentiated lymphoma, Burkitt's type) in American adults: results with treatment designed for acute lymphoblastic leukemia.

Straus DJ, Wong GY, Liu J, Oppenberg J, Filippa DA, Gold JW, Offit K, Clarkson BD.

Am J Med. 1991 Mar;90(3):328-37.

PMID:
2003515
46.

A phase I trial of monoclonal antibody M195 in acute myelogenous leukemia: specific bone marrow targeting and internalization of radionuclide.

Scheinberg DA, Lovett D, Divgi CR, Graham MC, Berman E, Pentlow K, Feirt N, Finn RD, Clarkson BD, Gee TS, et al.

J Clin Oncol. 1991 Mar;9(3):478-90.

PMID:
1999719
47.

Factors affecting the outcome of autologous bone marrow transplantation.

Gulati SC, Yahalom J, Whitmarsh K, Clarkson BD, Gee T.

Ann Oncol. 1991 Jan;2 Suppl 1:51-5.

PMID:
2043499
48.
49.

Purging of myeloma cells from bone marrow using monoclonal antibodies and magnetic immunobeads in combination with 4-hydroperoxycyclophosphamide.

Shimazaki C, Inaba T, Murakami S, Fujita N, Nakagawa M, Gulati SC, Fried J, Clarkson BD, Wisniewolski R, Wang CY.

Prog Clin Biol Res. 1990;333:311-9. No abstract available.

PMID:
2308988
50.

Fusarium infections in patients with hematologic malignancies.

Schneller FR, Gulati SC, Cunningham IB, O'Reilly RJ, Schmitt HJ, Clarkson BD.

Leuk Res. 1990;14(11-12):961-6.

PMID:
2280611

Supplemental Content

Loading ...
Support Center